Genomic evidence for reinfection with SARS-CoV-2: a case study.

MLA

Tillett, Richard L., et al. “Genomic Evidence for Reinfection with SARS-CoV-2: A Case Study.” The Lancet. Infectious Diseases, vol. 21, no. 1, Jan. 2021, pp. 52–58. EBSCOhost, https://doi.org/10.1016/S1473-3099(20)30764-7.

APA

Tillett, R. L., Sevinsky, J. R., Hartley, P. D., Kerwin, H., Crawford, N., Gorzalski, A., Laverdure, C., Verma, S. C., Rossetto, C. C., Jackson, D., Farrell, M. J., Van Hooser, S., & Pandori, M. (2021). Genomic evidence for reinfection with SARS-CoV-2: a case study. The Lancet. Infectious Diseases, 21(1), 52–58. https://doi.org/10.1016/S1473-3099(20)30764-7

Chicago

Tillett, Richard L, Joel R Sevinsky, Paul D Hartley, Heather Kerwin, Natalie Crawford, Andrew Gorzalski, Chris Laverdure, et al. 2021. “Genomic Evidence for Reinfection with SARS-CoV-2: A Case Study.” The Lancet. Infectious Diseases 21 (1): 52–58. doi:10.1016/S1473-3099(20)30764-7.